{"DataElement":{"publicId":"2855056","version":"1","preferredName":"Chronic Graft Versus Host Disease Severity Score","preferredDefinition":"Numeric value that represents the global rating or score for the intensity or severity of an individual's chronic Graft vs. Host Disease (GVHD).","longName":"CGVHD_SVRTY_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2855050","version":"1","preferredName":"Chronic Graft Versus Host Disease Severity Assessment","preferredDefinition":"information related to the severity of graft versus host disease following transplant._A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Used of the degree of something undesirable e.g. pain or weather; also, strictness._The final result of a determination of the value, significance, or extent of.","longName":"CGVHD_SVRTY_ASSESS","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2512832","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing more than 100 days post-transplant.","longName":"C4981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8985BC-2113-374B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2855048","version":"1","preferredName":"Severity Assessment","preferredDefinition":"Severity; used of the degree of something undesirable e.g. pain or weather.:Having determined the value, significance, or extent of.","longName":"C25676:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CCDBF3-42FD-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CCDBF3-430E-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2855052","version":"1","preferredName":"Graft Versus Host Disease Severity  Score","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing._Category; used informally to mean a class of things._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"GVHD_SVRTY_SC","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65CCDBF3-4349-57E0-E040-BB89AD432F3B","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","deletedIndicator":"No"},{"value":"1","valueDescription":"Mild","ValueMeaning":{"publicId":"2795871","version":"1","preferredName":"Mild","longName":"2795871","preferredDefinition":"Gentle or temperate in nature or degree.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59EE-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"65CCDBF3-435D-57E0-E040-BB89AD432F3B","beginDate":"2008-10-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate","ValueMeaning":{"publicId":"2795872","version":"1","preferredName":"Moderate","longName":"2795872","preferredDefinition":"The quality of being within reasonable or average limits; not excessive or extreme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate","conceptCode":"C61376","definition":"The quality of being within reasonable or average limits; not excessive or extreme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-5A13-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"65CCDBF3-4371-57E0-E040-BB89AD432F3B","beginDate":"2008-10-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","deletedIndicator":"No"},{"value":"3","valueDescription":"Severe","ValueMeaning":{"publicId":"2795870","version":"1","preferredName":"Severe","longName":"2795870","preferredDefinition":"Intensely bad or unpleasant in degree, quality or extent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59C9-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"65CCDBF3-4385-57E0-E040-BB89AD432F3B","beginDate":"2008-10-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2855058","version":"1","preferredName":"Graft Versus Host Disease Severity Score","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.:Severity; used of the degree of something undesirable e.g. pain or weather.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C3063:C25676:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CE19B1-0D86-3B64-E040-BB89AD437B15","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"ONEDATA","dateModified":"2009-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CCDBF3-4334-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"COOPERM","dateModified":"2016-04-22","changeDescription":"11/14/08mn-added max length 60.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinician Global Rating - Sev","type":"Preferred Question Text","description":"Clinician Global Rating - Severity of cGVHD","url":null,"context":"CCR"},{"name":"Severity (0-3) Score","type":"Alternate Question Text","description":"Severity (0-3) Score","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65CCDBF3-43B0-57E0-E040-BB89AD432F3B","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-23","modifiedBy":"SBR","dateModified":"2016-11-20","changeDescription":"Curated to support CCR Transplant study 08C0097.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}